| Name | N'-(3-chloro-4-morpholin-4-ylphenyl)-N-hydroxymethanimidamide |
|---|---|
| Synonyms |
TS-011
Methanimidamide,N-[3-chloro-4-(4-morpholinyl)phenyl]-N'-hydroxy |
| Description | TS-011 is a selective inhibitor of 20-Hydroxyeicosatetraenoic acid synthesis. |
|---|---|
| Related Catalog | |
| In Vivo | TS-011 is a selective inhibitor of 20-Hydroxyeicosatetraenoic acidsynthesis. TS-011 at a dose of 0.3 mg/kg inhibits the reduction in the blood flow velocities at 1 and 7 h after reperfusion (P<0.001). In addition, TS-011 inhibits the increase in the blood flow velocity at 24 h after reperfusion (P<0.01). TS-011 protects the microvascular perfusion area from the loss observed in vehicle-treated mice. TS-011, at a dose of 0.3 mg/kg, also reduces the infarct volume by almost 40% (P<0.05)[1]. In 9 dogs with delayed vasospasm, acute blockade of the synthesis of 20-HETE with TS-011 (1 mg/kg IV) significantly increases the diameter of the basilar artery by 39%[2]. |
| Animal Admin | The studies are performed using 58 male C57BL/6J mice (8 weeks old) weighing 20 to 26 g. TS-011 (0.3 mg/kg) or a vehicle is infused intravenously for 1 h every 6 h in a mouse model of stroke, induced by transient occlusion of the middle cerebral artery occlusion following photothrombosis. The cerebral blood flow velocity and the vascular perfusion area of the peri-infarct microvessels are measured using in vivo two-photon imaging[1]. |
| References |
| Boiling Point | 477.8±55.0°C |
|---|---|
| Molecular Formula | C11H14ClN3O2 |
| Molecular Weight | 255.70100 |
| Exact Mass | 255.07700 |
| PSA | 57.09000 |
| LogP | 2.27110 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|